Loading...
XWAR
MDG
Market cap63mUSD
Oct 09, Last price  
25.00PLN
1D
-0.40%
1Q
-9.75%
Jan 2017
-91.88%
IPO
19.05%
Name

Medicalgorithmics SA

Chart & performance

D1W1MN
XWAR:MDG chart
P/E
—
P/S
8.03
EPS
—
Div yield, %
—
Shrs. gr., 5y
19.19%
Rev. gr., 5y
-22.63%
Revenues
31m
+29.09%
4,107,3115,804,96610,961,65815,697,40029,714,10049,330,500127,921,000203,354,000199,404,000173,870,000111,734,00048,349,00062,719,00043,098,00024,002,00030,985,000
Net income
-12m
L-27.34%
1,909,9853,005,8727,438,75210,874,10014,526,30013,925,40040,108,00025,539,00014,416,000-299,000-12,919,000-180,638,000-11,862,000-578,000-16,081,000-11,684,000
CFO
-2m
L-86.07%
1,669,3692,688,8184,112,9205,576,900-2,907,70017,347,10035,477,00028,611,00044,232,00013,499,000-3,956,000-6,479,0006,331,000182,000-13,079,000-1,822,000
Dividend
Jul 13, 20181.42 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2005 and headquartered in Warsaw, Poland, Medicalgorithmics S.A. is a prominent provider of cardiac diagnostic solutions, serving markets in Poland, the United States, and globally. The company offers an array of advanced products, including PocketECG, a comprehensive diagnostic system for arrhythmia detection that furnishes detailed ECG signals, data analysis, and exhaustive reports. Another key offering is PocketECG CRS, specifically designed for monitoring patients during cardiac rehabilitation. Its technological portfolio also encompasses ECG TechBot, a software program that utilizes algorithms for the automated analysis and interpretation of ECG signals, and PatchECG, a device enabling single-channel, offline heart monitoring. Additionally, PocketECG IV enhances the core PocketECG device by enabling continuous ECG signal transmission via LTE connectivity. Beyond its innovative devices, Medicalgorithmics S.A. delivers services in information technology, biotechnology, ECG monitoring, and scientific research and development, alongside manufacturing and distributing electro-medical equipment.

Key people

Krzysztof Siemionow
President of the Management Board, Chief Executive Officer · since 2025
Vice Chairman of the Supervisory Board · since 2021
Przemyslaw Tadla
Chief Technology Officer · since 2025
Chief Financial Officer, Member of the Management Board · since 2021
Jaroslaw Jerzakowski
Member of the Management Board · since 2021
Michal Zapora
Chief Financial Officer, Member of the Management Board · since 2025
Michal Zoltowski
Chairman of the Supervisory Board
Independent Member of the Supervisory Board · since 2018
Werner Engelhardt
Member of the Supervisory Board · since 2021
Pawel Lewicki
Member of the Supervisory Board
Independent Member of the Supervisory Board · since 2015
Mariusz Matuszewski
Independent Member of the Supervisory Board · since 2019
Marzena Piszczek
Member of the Supervisory Board
Member of the Supervisory Board · since 2021
Brandon Von Tobel
Member of the Supervisory Board · since 2021
IPO date
Nov 09, 2011
Employees
122
Domiciled in
PL
Incorporated in
PL
Headquarters & legal address
WARSZAWA AL. JEROZOLIMSKIE 81
WARSZAWA, 14 02-001
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT